Meyka AI API is live for developers.Start building.
Advertisement
iSpecimen Inc.

iSpecimen Inc. (ISPC) Stock Overview

Explore iSpecimen Inc.’s financial performance, market position, analyst ratings, and future outlook.

ISPCNASDAQ
HealthcareMedical - Diagnostics & Research
$3.02
$0.16(5.03%)
U.S. Market opens in 51h 58m
Advertisement

iSpecimen Inc. (ISPC)

Meyka AI Score

Z

Key Financials

Market Cap419.4K
P/E Ratio-0.00
EPS (TTM)$-329.05
ROE-5.85%
Fundamental Analysis

AI Price Forecasts

1 Month$0.04
3 Months$0.29
1 Year Target$0.00

ISPC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iSpecimen Inc. (ISPC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 419.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.03%
5-Day Change
-9.04%
1-Month Change
-49.07%
3-Month Change
-69.43%
6-Month Change
-84.38%
Year-to-Date (YTD) Change
-70.96%
1-Year Change
-94.01%
3-Year Change
-99.70%
5-Year Change
-99.95%
All-Time (Max) Change
-99.95%

Contact Information

781 301 6700
450 Bedford Street, Woburn, MA, 02420

Company Facts

24 Employees
IPO DateJun 17, 2021
CountryUS
Actively Trading

Frequently Asked Questions